Abstract |
Tumor growth is partly dependent on tumor-associated angiogenesis, which is regulated by angiogenic growth factors. As the first angiogenic growth factor to be identified, basic fibroblast growth factor (bFGF) plays a major role in angiogensis and tumor growth and has been an effective target for anti- tumor therapy. However, due to its low immunogenicity, injection with bFGF alone cannot stimulate the body to produce a strong immune response. In this study, we investigated the role of CF (containing bFGF and CRM197) assisted by CpG and alum in enhancing antigen-specific immune response and suppressing the growth of murine colon carcinoma. The results revealed that compared to bFGF, CF could not stimulate NIH-3T3 fibroblast proliferation even at a concentration of 10 µg/ml in vitro. In vivo, the CF-CpG- alum produced a stronger antigen-specific immune response and inhibited tumor growth. The anti- tumor activity was associated with generating antigen-specific antibody, suppressing angiogenesis, promoting the apoptosis of tumor cells and inducing the mixed Th1 and Th2 responses. This indicates that CRM197 may be an innovative intramolecular adjuvant and provides a rational preservation for mouse CT26 colon carcinoma.
|
Authors | Hai-Long Zhang, Chuang Yuan, Dong-Mei Zhang, Hua-Shan Shi, Meng Li, Zi-Chao Luo, Yang Wan, Lian Lu, Shun-Tao Luo, Li Yang |
Journal | Molecular medicine reports
(Mol Med Rep)
2011 Sep-Oct
Vol. 4
Issue 5
Pg. 857-63
ISSN: 1791-3004 [Electronic] Greece |
PMID | 21720718
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Alum Compounds
- Bacterial Proteins
- CPG-oligonucleotide
- Cancer Vaccines
- Carrier Proteins
- Immunoglobulin G
- Oligodeoxyribonucleotides
- Platelet Endothelial Cell Adhesion Molecule-1
- Recombinant Fusion Proteins
- Vaccines, Conjugate
- CRM197 (non-toxic variant of diphtheria toxin)
- Fibroblast Growth Factor 2
- aluminum sulfate
|
Topics |
- Alum Compounds
- Animals
- Apoptosis
- Bacterial Proteins
(immunology, toxicity)
- Cancer Vaccines
(immunology, toxicity)
- Carrier Proteins
(immunology)
- Female
- Fibroblast Growth Factor 2
(immunology)
- Genetic Vectors
(genetics)
- Humans
- Immunity
(immunology)
- Immunoglobulin G
(blood, classification, immunology)
- In Situ Nick-End Labeling
- Mice
- Mice, Inbred BALB C
- NIH 3T3 Cells
- Neoplasms
(blood supply, immunology)
- Neovascularization, Pathologic
(pathology)
- Oligodeoxyribonucleotides
(immunology)
- Platelet Endothelial Cell Adhesion Molecule-1
(metabolism)
- Recombinant Fusion Proteins
(isolation & purification)
- Treatment Outcome
- Vaccines, Conjugate
(immunology, toxicity)
|